Skip to content
OpenCapital
Get started

Dolby Laboratories, Inc. DLB Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value

Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value at other companies

Repligen logo
RepligenRGEN
$155.80—
Repligen logo
RepligenRGEN
$129.34—
PNC Financial Services logo
PNC Financial ServicesPNC
$190.93+34.7%
Repligen logo
RepligenRGEN
$165.09—
Granite Point Mortgage Trust logo
Granite Point Mortgage TrustGPMT
$4.04-32.1%
Keysight Technologies logo
Keysight TechnologiesKEYS
$163.00+3.8%

Other financials

Income statement

See full
Revenue$395.6M+7.1%
Gross profit$350.9M+5.1%
Operating income$112.9M+4.8%
Net income$94.9M+3.4%
EPS (diluted)$0.99+5.3%

Balance sheet

See full
Cash & equivalents$673.8M-10.2%
Total debt$49.7M+22.9%
Total equity$2.6B+1.7%
Total assets$3.2B+0.6%

Cash flow

See full
Operating cash flow$92.5M-47.1%
CapEx$9.1M+31.4%
Free cash flow$83.4M-50.3%

Valuation

See full
Market cap$4.95B-25.9%

Profitability

See full
Gross margin87.4%-1.5pp
Operating margin18.5%-2.0pp
Net margin17.9%-1.6pp
FCF margin22.1%-7.5pp

Returns & leverage

See full
Return on equity9.4%-0.9pp
Debt / equity0×0.0×
Current ratio3×-0.1×

Where this comes from

Reported directly by Dolby Laboratories, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue.

The official record: Dolby Laboratories, Inc.’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Dolby Laboratories, Inc.'s share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Dolby Laboratories, Inc.'s share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value?
Dolby Laboratories, Inc. (DLB) reported share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value of $70.87 in Q1 2026.
How has Dolby Laboratories, Inc.'s share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value changed year-over-year?
Dolby Laboratories, Inc.'s share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value decreased by 8.4% year-over-year, from $77.35 to $70.87.
What is the long-term trend for Dolby Laboratories, Inc.'s share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value?
Over 5 years (2020 to 2025), Dolby Laboratories, Inc.'s share based compensation arrangement by share based payment award equity instruments other than options nonvested weighted average grant date fair value has grown at a 4.2% compound annual growth rate (CAGR), from $62.7 to $77.07.